“Venetoclax and Azacitidine Combination Therapy in Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia”, ALR, vol. 5, no. 1, pp. 19–24, Nov. 2024, doi: 10.5281/zenodo.22227795.